The findings suggest that disease-associated microbes can actively drive intestinal inflammation by reshaping host metabolism, suggesting new therapeutic possibilities to prevent or disrupt diseases like infectious diarrhea and colorectal cancer.

The findings suggest the gut microbiota — microorganisms that live in the intestines — could be a therapeutic target to prevent hospital-acquired lung infections.

Badly burned as a child, Bohannon is committed to developing better therapies for burn patients.

The National Academy of Sciences’ program identifies future leaders of science and brings them together to develop their leadership potential.

A multi-institutional study led by Vanderbilt Health investigators provides a spatial understanding of thyroid cancer evolution and identifies cell types that may predict aggressive disease in both children and adults.

Gaddy is a leading researcher in bacterial pathogenesis, innate immunity and reproductive immunology.

Treatment options are limited for the more than 500,000 people in the U.S. who are diagnosed annually with C. diff infections, but researchers are working on potential vaccines, therapeutic antibodies and — most recently — nanobodies, to prevent and treat C. diff infections.